Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688799 Hunan Warrant Pharmaceutical
- 48.61
- +2.62+5.70%
Market Closed Apr 24 15:00 CST
4.56BMarket Cap31.34P/E (TTM)
49.30High46.13Low48.62KlotVolume46.13Open45.99Pre Close235.38MTurnover5.18%Turnover Ratio27.75P/E (Static)93.80MShares55.1052wk High2.46P/B4.56BFloat Cap32.8852wk Low55.19Limit Up93.80MShs Float67.48Historical High36.79Limit Down6.89%Amplitude25.81Historical Low0.90Dividend TTM48.41Avg Price21.56KlotAsk1.85%Div YieldTTM100Lot Size23.60KlotBid
Hunan Warrant Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -73.02%124.51M | -53.18%177.74M | -23.69%118.09M | 150.92%306.34M | 36.19%461.51M | 98.47%379.65M | -56.87%154.75M | -64.21%122.09M | 1.59%338.86M | -45.87%191.29M |
| Transactional financial assets | --180M | 1,120.00%183M | -22.67%232M | -98.21%5M | ---- | -95.38%15M | -5.06%300M | -6.67%280M | -58.33%170M | -18.75%325M |
| Notes receivable and accounts receivable | 2.77%195.74M | 13.27%187.66M | 27.04%182.62M | 32.39%205.96M | 25.34%190.46M | 3.66%165.67M | -12.78%143.74M | 18.08%155.57M | 14.29%151.95M | 23.94%159.82M |
| -Notes receivable | 149.31%29.01M | 103.41%19.35M | 116.48%20.18M | 36.14%13.24M | 83.38%11.64M | 165.87%9.51M | 140.65%9.32M | 212.26%9.72M | 147.90%6.35M | -47.60%3.58M |
| -Accounts receivable | -6.76%166.73M | 7.78%168.31M | 20.84%162.43M | 32.13%192.72M | 22.81%178.83M | -0.06%156.15M | -16.47%134.42M | 13.38%145.85M | 11.66%145.61M | 27.94%156.25M |
| Other receivables (including interest and dividends) | 358.95%10.93M | 672.28%16.5M | 9.46%2.65M | -6.37%2.16M | 13.00%2.38M | -2.66%2.14M | 13.81%2.42M | 23.56%2.3M | -9.98%2.11M | 47.72%2.19M |
| -Other receivable | ---- | 672.28%16.5M | ---- | -6.37%2.16M | ---- | -2.66%2.14M | ---- | 23.56%2.3M | ---- | 47.72%2.19M |
| Advance payment | 178.23%33.69M | 1.26%15.22M | 155.38%25.41M | 667.99%18.85M | 201.90%12.11M | 189.82%15.03M | 144.93%9.95M | 12.69%2.46M | -41.56%4.01M | 21.12%5.19M |
| Inventories | 12.98%416.3M | 13.72%412.43M | 28.56%422.74M | 15.84%400.17M | 13.36%368.48M | 6.90%362.67M | -3.53%328.83M | 0.72%345.45M | 0.12%325.04M | 12.89%339.26M |
| Receivable financing | 0.59%25.17M | 115.54%38.53M | 10.88%22.66M | 11.54%25.4M | 4.20%25.02M | -13.69%17.88M | 173.84%20.44M | 340.93%22.77M | 307.35%24.02M | 8,388.81%20.71M |
| Other current assets | 14.68%403.35M | 2.67%402.19M | 28.67%470.45M | 26.29%474.97M | 38.42%351.72M | 91.20%391.72M | 2,748.37%365.62M | 13,356.00%376.1M | 3,129.74%254.1M | 1,098.27%204.87M |
| Total current assets | -1.56%1.39B | 6.19%1.43B | 11.38%1.48B | 10.11%1.44B | 11.15%1.41B | 8.12%1.35B | 9.84%1.33B | 15.86%1.31B | 3.92%1.27B | 3.51%1.25B |
| Non Current assets | ||||||||||
| Investment real estate | -2.92%5.7M | -2.90%5.74M | -2.83%5.79M | -2.81%5.83M | -2.79%5.87M | -2.77%5.92M | -2.75%5.96M | -51.27%6M | -51.28%6.04M | -51.29%6.08M |
| Fixed assets | ---- | -4.43%543.94M | ---- | -5.46%562.71M | ---- | 15.38%569.15M | ---- | 22.66%595.21M | ---- | 14.73%493.27M |
| Constru in process | ---- | 417.88%143.06M | ---- | 2,316.56%86.87M | ---- | -60.82%27.62M | ---- | -81.28%3.59M | ---- | 63.76%70.5M |
| Intangible assets | 143.93%184.3M | 142.87%186.09M | -3.46%75.04M | -5.26%74.68M | -5.49%75.56M | -5.48%76.62M | -4.79%77.72M | -4.10%78.83M | -3.99%79.95M | 40.82%81.06M |
| Goodwill | 0.00%32.38M | 0.00%32.38M | 0.00%32.38M | 0.00%32.38M | 0.00%32.38M | 0.00%32.38M | 0.00%32.38M | 0.00%32.38M | 0.00%32.38M | --32.38M |
| Long deferred expense | 89.42%9.88M | 96.14%10.44M | 112.42%6.35M | 83.10%4.86M | 76.34%5.21M | 63.32%5.32M | 1,598.25%2.99M | 1,257.30%2.65M | 1,161.23%2.96M | 1,290.21%3.26M |
| Deferred tax assets | 83.28%35.52M | 112.52%39.81M | 61.75%22.45M | 33.84%22.31M | -3.41%19.38M | 31.95%18.73M | -14.38%13.88M | -2.30%16.67M | 57.02%20.06M | 15.51%14.2M |
| Other non current assets | 67.36%72.83M | -51.69%21.4M | 39.76%56.36M | 79.33%36.4M | 117.58%43.52M | 85.85%44.29M | 97.05%40.33M | -9.06%20.3M | -2.70%20M | 1,165.17%23.83M |
| Total non current assets | 26.49%1.08B | 24.08%1.03B | 13.49%903.35M | 12.62%889.74M | 9.75%854.72M | 8.75%827.2M | 9.75%795.95M | 11.75%790.02M | 11.72%778.82M | 28.58%760.63M |
| Total assets | 9.02%2.47B | 12.99%2.46B | 12.17%2.38B | 11.06%2.33B | 10.61%2.27B | 8.36%2.18B | 9.80%2.12B | 14.28%2.1B | 6.76%2.05B | 11.76%2.01B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --2.65M | --3.77M | --1.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | 17.34%120.41M | 114.84%192.28M | 130.88%141.9M | 39.19%141.76M | 20.67%102.62M | 25.83%89.5M | -17.92%61.46M | 74.84%101.85M | -11.01%85.04M | -12.08%71.13M |
| -Notes payable | --20M | --32.36M | --22.36M | 94.65%10M | ---- | ---- | ---- | -70.16%5.14M | 73.12%15.19M | --10.05M |
| -Accounts payable | -2.15%100.41M | 78.68%159.92M | 94.50%119.54M | 36.24%131.76M | 46.90%102.62M | 46.53%89.5M | -7.48%61.46M | 135.69%96.71M | -19.52%69.86M | -24.50%61.08M |
| Contract liabilities | 26.17%89.29M | 0.44%76.45M | 32.01%74.03M | 20.31%75.16M | 12.68%70.77M | -2.46%76.11M | 19.68%56.08M | 35.22%62.47M | 25.25%62.81M | 41.43%78.03M |
| Advance receipts | 81.17%9.14M | 212.39%12.54M | 94.28%10.5M | 67.40%7.76M | 27.13%5.05M | -8.32%4.01M | 92.16%5.4M | 57.20%4.64M | -45.35%3.97M | -42.24%4.38M |
| Salaries payable | 0.26%15.09M | 21.95%23.44M | -19.16%11.94M | -18.54%11.83M | 9.60%15.05M | 6.16%19.22M | 34.60%14.78M | 42.44%14.52M | 29.57%13.73M | 10.80%18.1M |
| Taxs payable | -4.32%19.78M | -9.73%16.13M | -60.08%6.92M | 342.48%20.75M | 47.74%20.67M | 318.19%17.87M | -35.07%17.33M | -75.35%4.69M | 14.73%13.99M | -22.80%4.27M |
| Other payable (including interest and dividends) | -38.88%72.62M | -36.85%74.62M | -31.79%64.3M | -8.93%69.06M | 11.70%118.8M | 7.04%118.16M | -12.12%94.26M | 6.14%75.84M | 9.55%106.36M | 33.36%110.39M |
| -Other payable | ---- | -36.85%74.62M | ---- | -8.93%69.06M | ---- | 7.04%118.16M | ---- | 6.14%75.84M | ---- | 33.36%110.39M |
| Non current liabilities due within one year | 537.93%230.85K | 273.58%51.12K | --62.58K | --48.86K | --36.19K | --13.69K | ---- | ---- | ---- | ---- |
| Other current liabilities | 150.18%29.74M | 71.92%19.75M | 80.11%20.18M | 3.67%12.49M | 119.60%11.89M | 34.67%11.48M | 84.69%11.2M | 122.05%12.04M | -3.63%5.41M | -24.48%8.53M |
| Total current liabilities | 4.08%358.95M | 24.57%419.02M | 27.04%330.95M | 22.75%338.87M | 18.39%344.89M | 14.09%336.38M | -5.45%260.52M | 29.30%276.05M | 4.61%291.32M | 13.57%294.83M |
| Current liabilities | ||||||||||
| Estimate liabilities | 0.00%5.28M | 0.00%5.28M | 0.00%5.28M | 0.00%5.28M | --5.28M | --5.28M | --5.28M | --5.28M | ---- | ---- |
| Deferred tax liabilities | ---- | --24.1K | ---- | ---- | ---- | ---- | 74,492.15%2.16M | 42,727.93%2.3M | 35,126.65%2.32M | 35,189.79%2.33M |
| Long term deferred income | 101.23%97.42M | 97.85%98.8M | -10.08%45.35M | -8.51%46.88M | -6.84%48.41M | -6.11%49.94M | -5.32%50.44M | -5.92%51.24M | -6.84%51.97M | -6.56%53.19M |
| Total non current liabilities | 135.66%237.16M | 201.46%218.04M | 144.38%141.44M | 107.44%122.02M | 85.37%100.64M | 30.28%72.33M | 8.64%57.88M | 7.98%58.82M | -2.69%54.29M | -5.06%55.52M |
| Total liabilities | 33.80%596.11M | 55.87%637.06M | 48.37%472.4M | 37.63%460.89M | 28.91%445.53M | 16.66%408.7M | -3.17%318.4M | 24.97%334.87M | 3.39%345.6M | 10.15%350.35M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M | 0.00%93.8M |
| Capital reserve funds | 0.97%858.61M | 0.00%850.34M | 0.00%850.34M | 0.00%850.34M | 0.00%850.34M | 0.00%850.34M | 0.00%850.34M | 0.00%850.34M | 0.00%850.34M | 0.00%850.34M |
| Surplus reserve funds | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M | 0.00%46.9M |
| Retained profit | 7.70%853.55M | 10.91%812.37M | 16.63%890.88M | 17.76%845.26M | 21.03%792.52M | 20.96%732.47M | 39.67%763.85M | 41.69%717.78M | 25.32%654.83M | 23.98%605.57M |
| Shareholders equity without minority interests | 3.88%1.85B | 4.64%1.8B | 7.24%1.88B | 7.46%1.84B | 8.37%1.78B | 7.95%1.72B | 14.11%1.75B | 14.10%1.71B | 8.74%1.65B | 7.92%1.6B |
| Minority interests | -41.34%21.89M | -57.14%19.17M | -47.01%25.66M | -40.84%31.4M | -35.04%37.31M | -27.87%44.73M | -26.05%48.42M | -23.36%53.07M | -19.59%57.43M | --62.01M |
| Total shareholder equity | 2.96%1.87B | 3.07%1.82B | 5.78%1.91B | 6.01%1.87B | 6.90%1.82B | 6.61%1.77B | 12.47%1.8B | 12.45%1.76B | 7.47%1.7B | 12.11%1.66B |
| Total liabilityies and equity | 9.02%2.47B | 12.99%2.46B | 12.17%2.38B | 11.06%2.33B | 10.61%2.27B | 8.36%2.18B | 9.80%2.12B | 14.28%2.1B | 6.76%2.05B | 11.76%2.01B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.